Sambratha Shetty
Chief Operating Officer, Synergia Foundation
A clear picture of India’s drug discovery
India’s domestic pharmaceutical industry excels in the production of generic medicines but the rate of drug discovery is staggeringly below the global industry average. Drug discovery is an expensive, slow and risky business and most Indian companies do not have sufficient financial resources to take the risk to develop a new drug from scratch. Does India have the resources to become the pharmaceutical powerhouse, it aspires to be?
To read the full research paper, Subscribe.
G.K. Pillai
Former Home Secretary, Government of India
Uncovering Trends in Security
P.C. Haldar
Former Director of Intelligence Bureau, GoI
Cyber 9/11
Lt. Gen. Philip Campose
Former Vice Chief of the Indian Army
Optimal Warfare
V. Balachandran
Former Special Secretary, Cabinet Secretariat, GOI
Reorganizing Urban Disaster Management
Praveen Swami
National Editor, The Indian Express
India's Capacity Crisis
